The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,6-Difluoro-3-((4-(2,4-dichlorophenyl)-5-oxo-1,3,4-oxadiazol-2-yl)methoxy)benzamide ID: ALA4471088
PubChem CID: 155534991
Max Phase: Preclinical
Molecular Formula: C16H9Cl2F2N3O4
Molecular Weight: 416.17
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1c(F)ccc(OCc2nn(-c3ccc(Cl)cc3Cl)c(=O)o2)c1F
Standard InChI: InChI=1S/C16H9Cl2F2N3O4/c17-7-1-3-10(8(18)5-7)23-16(25)27-12(22-23)6-26-11-4-2-9(19)13(14(11)20)15(21)24/h1-5H,6H2,(H2,21,24)
Standard InChI Key: YYRICWNQHTUKEK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
29.8319 -5.7073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6491 -5.7073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9034 -4.9305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2405 -4.4484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5817 -4.9305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0414 -3.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0402 -4.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7483 -4.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4580 -4.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4551 -3.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7465 -3.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1613 -3.2914 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.3336 -3.2978 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.7441 -2.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4506 -2.0695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0351 -2.0737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1663 -4.9328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8734 -4.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1286 -6.3689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6063 -4.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3170 -4.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0195 -4.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0116 -3.6872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2955 -3.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5960 -3.7034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8829 -3.3042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.7146 -3.2705 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
10 12 1 0
6 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
9 17 1 0
17 18 1 0
18 5 1 0
2 19 2 0
3 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
23 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.17Molecular Weight (Monoisotopic): 414.9938AlogP: 3.09#Rotatable Bonds: 5Polar Surface Area: 100.35Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.96CX Basic pKa: ┄CX LogP: 3.55CX LogD: 3.55Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -1.65
References 1. Bi F, Song D, Qin Y, Liu X, Teng Y, Zhang N, Zhang P, Zhang N, Ma S.. (2019) Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains., 27 (14): [PMID:31200986 ] [10.1016/j.bmc.2019.06.010 ]